Claritin Reditabs

   
Google
 
Web NewDrugInformation.com

Claritin Reditabs


Drug - Claritin Reditabs
The trade name of the product as shown on the labeling.

Dosage - TABLET, ORALLY DISINTEGRATING; ORAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Loratadine
Multiple ingredients are in alphabetical order.

Strength - 10MG
The potency of the active ingredient(s), Loratadine. May repeat for multiple part products.

Applicant - SCHERING PLOUGH
The firm name holding legal responsibility for Claritin Reditabs. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 020704
The FDA assigned number to Claritin Reditabs. Format is nnnnnn.

Product Number - 002
The FDA assigned number to identify Claritin Reditabs. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Nov 27, 2002
The date Claritin Reditabs was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - Yes
The pioneer or innovator of Claritin Reditabs. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - OTC
The group or category of approved drugs Claritin Reditabs is in. Format is RX, OTC, DISCN.

Applicant Full Name - Schering Plough Healthcare Products Inc
The full name of the firm holding legal responsibility for the new application of Claritin Reditabs.

Claritin Reditabs